Rasio cepet: Autonomix Medical Inc. (AMIX)

Autonomix Medical, Inc. (AMIX) develops advanced neuromodulation sensors that enable physicians to monitor nerve impulses with maximum precision during interventions. Business efficiency relies on a streamlined supply chain of precision catheters, which minimizes equipment shortages and guarantees stable profits. This price action for the securities on GURU.Markets, where the coefficient is 5.01, confirms the company's dominance in the microsensor pain suppression niche due to rigorous patent protection.

To select high-quality assets, investors must evaluate an issuer's real solvency excluding illiquid inventories. This ratio measures the ability to settle short-term obligations using exclusively cash and accounts receivable. For Autonomix Medical, Inc. (AMIX) during its clinical testing phase and FDA preparation, this is a critical survival marker. The trend of the critical assessment ratio clearly demonstrates the startup's financial cushion.